#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thalassaemia alpha Dementia Alzheimer's type Angelman's syndrome Hepatocellular carcinoma Chronic granulomatous disease Aspergillus infection Hypergammaglobulinaemia benign monoclonal Marginal zone lymphoma recurrent Fusarium infection Mantle cell lymphoma recurrent Dementia with Lewy bodies Anti-HLA antibody test positive Immunodeficiency congenital Myelofibrosis Congenital ectodermal dysplasia More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III – Diagnostics Glycogen storage disease type I – Trials in Disease Alveolar rhabdomyosarcoma – Basic Information Splenic marginal zone lymphoma – Basic Information Mitochondrial myopathy – Basic Information Urea cycle disorder – Life with Disease Synovial sarcoma metastatic Mantle cell lymphoma stage IV – Diagnostics Thrombotic thrombocytopenic purpura – Treatment Rhabdomyosarcoma recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cx-044933 Amniotic Membrane, Human Human Plasma Protein Antiemetics And Antinauseants Grwd5769 ALKYLATING AGENTS Siplizumab Povidone Ucart22 Fosfomycin Gallium Citrate Ga-68 Tinlarebant Pegargiminase Inebilizumab Mitotane Azathioprine Paliperidone Sapropterin Dihydrochloride Ro7269162 Rmc-035 More therapies…

    Learn about Your Condition

    Asthma Extraskeletal ossification Neurotrophic keratopathy Appendicitis Metastatic neoplasm Diabetic foot infection Athetosis Osteonecrosis of jaw Oesophageal disorder HER2 positive breast cancer Alexander disease Connective tissue disorder Thermal burn Osteotomy Breast cancer metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on Esmolol for Heart Issues in Patients with Cirrhosis, Diabetes, or Cardiotoxic Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Esmolol Hydrochloride
    Spain

  • Study on the Effect of Aprepitant on Aldosterone Levels in Patients with Obstructive Sleep Apnea and High Blood Pressure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obstructive sleep apnoea syndrome
    • Hypertension
    Investigated Drugs:
    • Lactose Monohydrate
    France

  • Study on the Effectiveness of Denosumab for Treating Acute Charcot Foot in Diabetes Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Neuropathic arthropathy
    Investigated Drugs:
    • Denosumab
    Denmark

  • Study on the Safety and Effects of Efpegerglucagon in Children Aged 2 and Older with Congenital Hyperinsulinism

    Recruiting

    2 1 1
    Investigated Drugs:
    • Efpegerglucagon
    Germany

  • Study on the Effects of R3R01 on Reducing Protein in Urine for Patients with Diabetic Kidney Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic nephropathy
    Investigated Drugs:
    • Pentetic Acid
    • R3R01
    Denmark

  • Study on the Effect of Semaglutide in Patients with Type 1 Diabetes and Insulin Resistance

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    France
Previous Page
1 … 17 18 19 20 21 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!